Title: Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene
Subjects: Breast, Cancer, Immunotherapy, Trastuzumab, Metastasis, HER-2 protein, HER-2 gene